Alex E. Denes

482 total citations
15 papers, 340 citations indexed

About

Alex E. Denes is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Alex E. Denes has authored 15 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 3 papers in Genetics. Recurrent topics in Alex E. Denes's work include Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). Alex E. Denes is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Research Studies (2 papers) and Cancer therapeutics and mechanisms (2 papers). Alex E. Denes collaborates with scholars based in United States, India and United Kingdom. Alex E. Denes's co-authors include Florence Moog, Lee A. Rigg, Marc K. Wallack, Glenn P. Glasgow, John S. Meyer, John M. Bedwinek, Arthur L. Weaver, Seth H. Pincus, John Schindler and Frederick Wolfe and has published in prestigious journals such as Cancer, Developmental Biology and British Journal of Cancer.

In The Last Decade

Alex E. Denes

14 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex E. Denes United States	8	155	63	54	52	48	15	340
M Masuda Japan	10	118 0.8×	70 1.1×	36 0.7×	103 2.0×	42 0.9×	22	382
Sándor Dósa United States	14	65 0.4×	102 1.6×	50 0.9×	52 1.0×	57 1.2×	20	419
Shona Pendse United States	9	223 1.4×	169 2.7×	36 0.7×	71 1.4×	18 0.4×	11	457
Shigeru Furukawa Japan	10	95 0.6×	58 0.9×	34 0.6×	18 0.3×	51 1.1×	42	329
Masakatsu Imamura Japan	10	123 0.8×	62 1.0×	31 0.6×	146 2.8×	58 1.2×	15	360
H. Rainer Austria	10	119 0.8×	42 0.7×	37 0.7×	29 0.6×	41 0.9×	40	321
Tomoo Osumi Japan	11	104 0.7×	110 1.7×	31 0.6×	40 0.8×	15 0.3×	54	374
G Prentice Australia	7	103 0.7×	71 1.1×	22 0.4×	85 1.6×	20 0.4×	13	387
Gaosheng Huang China	13	122 0.8×	152 2.4×	35 0.6×	66 1.3×	16 0.3×	35	432
Laron McPhaul United States	14	49 0.3×	176 2.8×	37 0.7×	41 0.8×	29 0.6×	23	435

Countries citing papers authored by Alex E. Denes

Since Specialization

Citations

This map shows the geographic impact of Alex E. Denes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex E. Denes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex E. Denes more than expected).

Fields of papers citing papers by Alex E. Denes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex E. Denes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex E. Denes. The network helps show where Alex E. Denes may publish in the future.

Co-authorship network of co-authors of Alex E. Denes

This figure shows the co-authorship network connecting the top 25 collaborators of Alex E. Denes. A scholar is included among the top collaborators of Alex E. Denes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex E. Denes. Alex E. Denes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Ratner, Lee, Christian Grant, Gary J. Weil, et al.. (2007). Effect of treatment of Strongyloides infection on HTLV‐1 expression in a patient with adult T‐cell leukemia. American Journal of Hematology. 82(10). 929–931. 14 indexed citations

2.

Nervi, Bruno, Alex E. Denes, & Matthew J. Ellis. (2006). A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer. Digital Commons@Becker (Washington University School of Medicine). 9(1). 1–3. 1 indexed citations

3.

Fracasso, Paula M., Kristie A. Blum, Benjamin Tan, et al.. (2005). Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar. British Journal of Cancer. 93(1). 46–53. 24 indexed citations

4.

Faderl, Stefan, Steven Coutré, John C. Byrd, et al.. (2005). The evolving role of Alemtuzumab in management of patients with CLL. Leukemia. 19(12). 2147–2152. 21 indexed citations

5.

Green, Mark R., Michele Andrews, Richard D. Leff, et al.. (2005). Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data. Journal of Oncology Practice. 1(2). 37–42. 3 indexed citations

6.

Fracasso, Paula M., Janet S. Rader, Ramaswamy Govindan, et al.. (2002). Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. Annals of Oncology. 13(11). 1819–1825. 9 indexed citations

7.

Denes, Alex E., S. Evans, James Mason, et al.. (2000). The management of depression: the implications for managed care--roundtable discussion: Part 3.. PubMed. Suppl B. 26–32. 2 indexed citations

8.

Denes, Alex E.. (2000). The Role of Irinotecan in Non-Small Cell and Small-Cell Lung Cancer. Oncology Research and Treatment. 23(6). 25–27. 2 indexed citations

9.

Denes, Alex E., Arieh L. Shalhav, Gábor Kovács, & Ralph V. Clayman. (1998). Chronic lymphocytic leukemia remission following extra corporeal shock wave lithotripsy for urinary calculi. American Journal of Hematology. 58(3). 239–240. 2 indexed citations

10.

Denes, Alex E., Arieh L. Shalhav, Gábor Kovács, & Ralph V. Clayman. (1998). Chronic lymphocytic leukemia remission following extra corporeal shock wave lithotripsy for urinary calculi. American Journal of Hematology. 58(3). 239–240.

11.

Cannon, Grant W., Seth H. Pincus, Ronald Emkey, et al.. (1989). Double‐blind trial of recombinant γ‐interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis & Rheumatism. 32(8). 964–973. 85 indexed citations

12.

Presant, Cary A., et al.. (1984). Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma a comparative trial with 6-thioguanine. Cancer. 53(12). 2610–2614. 19 indexed citations

13.

Wallack, Marc K., John M. Bedwinek, Alex E. Denes, et al.. (1983). Gestational carcinoma of the female breast. Current Problems in Cancer. 7(9). 1–58. 95 indexed citations

14.

Denes, Alex E. & Cary A. Presant. (1979). 6-Thioguanine (TG): A phase I study of intermittent oral (PO) and intravenous (IV) therapy in solid tumors (ST). Proceedings of the American Association for Cancer Research. 20. 2 indexed citations

15.

Moog, Florence, et al.. (1973). Disaccharidases in the small intestine of the mouse: Normal development and influence of cortisone, actinomycin D, and cycloheximide. Developmental Biology. 35(1). 143–159. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact